Published in Ital J Gastroenterol Hepatol on February 01, 1997
Celiac disease and autoimmune thyroid disease. Clin Med Res (2007) 1.42
Cutaneous manifestations in celiac disease. World J Gastroenterol (2006) 1.16
Celiac disease in the elderly. Gastroenterol Clin North Am (2009) 0.95
Coeliac disease in Dutch patients with Hashimoto's thyroiditis and vice versa. World J Gastroenterol (2007) 0.93
Does gastric atrophy exist in children? World J Gastroenterol (2006) 0.79
Prevalence of coeliac disease in patients with autoimmune thyroiditis in a Turkish population. World J Gastroenterol (2007) 0.79
Celiac sprue: a unique autoimmune disorder. Expert Rev Clin Immunol (2009) 0.78
Spectrum of autoantibodies in celiac patients and relatives. Dig Dis Sci (2001) 0.78
Incomplete gastric metaplasia in children with insulin-dependent diabetes mellitus and celiac disease. An ultrastructural study. BMC Clin Pathol (2001) 0.75
Autoantibody frequency in celiac disease. Clinics (Sao Paulo) (2009) 0.75
Orbital myositis associated with celiac disease. Int Ophthalmol (2013) 0.75
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
The release of platelet-activating factor from human endothelial cells in culture. J Immunol (1983) 2.41
Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet (1984) 2.38
Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis (2006) 2.24
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology (1997) 2.21
Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis. Artif Organs (2001) 2.01
Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology (1981) 1.62
Autoimmune enteropathy and villous atrophy in adults. Lancet (1997) 1.62
Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats. J Cell Mol Med (2009) 1.58
Interleukin 1 stimulates platelet-activating factor production in cultured human endothelial cells. J Clin Invest (1986) 1.57
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut (2000) 1.53
The molecular action of tumor necrosis factor-alpha. Eur J Biochem (1991) 1.52
Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology (1974) 1.50
Prevalence of silent coeliac disease in atopics. Dig Liver Dis (2000) 1.48
Desmin and actin in the identification of Ito cells and in monitoring their evolution to myofibroblasts in experimental liver fibrosis. Virchows Arch B Cell Pathol Incl Mol Pathol (1988) 1.47
Abdominal lymphadenopathy detected by ultrasonography in HIV-1 infection: prevalence and significance. Scand J Infect Dis (1993) 1.44
Anti tissue transglutaminase antibodies as predictors of silent coeliac disease in patients with hypertransaminasaemia of unknown origin. Dig Liver Dis (2001) 1.44
Online clearance measurement in high-efficiency hemodiafiltration. Kidney Int (2007) 1.42
Bile duct cell apoptosis is a rare event in primary biliary cirrhosis. Dig Liver Dis (2001) 1.40
IgA antibodies to endomysium, gliadin, and reticulin in silent coeliac disease. Lancet (1992) 1.40
Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet (1991) 1.38
Thyroid function in systemic sclerosis. J Endocrinol Invest (1991) 1.38
High prevalence of celiac disease in Italian general population. Dig Dis Sci (2001) 1.34
Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci (1998) 1.34
Coeliac disease hidden by cryptogenic hypertransaminasaemia. Lancet (1998) 1.33
Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet (1990) 1.30
Antibodies to gliadin detected by immunofluorescence and a micro-ELISA method: markers of active childhood and adult coeliac disease. Gut (1985) 1.28
Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation. Int Arch Allergy Appl Immunol (1981) 1.27
Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets. Lab Invest (1984) 1.24
Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol (1985) 1.23
HCV and autoimmunity. Curr Pharm Des (2008) 1.22
Basement membrane production by hepatocytes in chronic liver disease. Hepatology (1985) 1.21
Mitochondrial antibodies in primary biliary cirrhosis. V. Ultrastructural localization of the antigen to the inner mitochondrial membrane using a direct peroxidase conjugate. Br J Exp Pathol (1973) 1.20
Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats. Kidney Int (2001) 1.17
IgA antiendomysial antibody test. A step forward in celiac disease screening. Dig Dis Sci (1991) 1.16
A linkage between hereditary hyperferritinaemia not related to iron overload and autosomal dominant congenital cataract. Br J Haematol (1995) 1.15
Evaluation of serum rosette inhibitory factors in chronic liver disease. Clin Exp Immunol (1983) 1.14
Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis. Hepatology (1996) 1.13
Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am J Gastroenterol (2001) 1.12
Quantitation of hepatitis C virus genome molecules in plasma samples. J Clin Microbiol (1994) 1.12
C reactive protein in patients with chronic renal diseases. Ren Fail (2001) 1.10
Ultrastructural localization and characterization of a ribosomal antibody detected by immunofluorescence in systemic lupus erythematosus. Clin Exp Immunol (1974) 1.10
Expression of co-stimulatory molecules by Kupffer cells in chronic hepatitis of hepatitis C virus etiology. Hepatology (1998) 1.09
Ito cell heterogeneity: desmin-negative Ito cells in normal rat liver. Hepatology (1994) 1.09
The epidemiology of cardiac surgery-associated acute kidney injury. Int J Artif Organs (2008) 1.08
Endothelial progenitor cell-derived microvesicles improve neovascularization in a murine model of hindlimb ischemia. Int J Immunopathol Pharmacol (2012) 1.07
Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor. Am J Pathol (1983) 1.07
Synthesis and release of platelet-activating factor is inhibited by plasma alpha 1-proteinase inhibitor or alpha 1-antichymotrypsin and is stimulated by proteinases. J Exp Med (1988) 1.07
Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium. Kidney Int (1998) 1.05
Ca(2+)-activated K+ transport in erythrocytes. Comparison of binding and transport inhibition by scorpion toxins. J Biol Chem (1993) 1.05
Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol (2003) 1.04
Anti-nuclear antibodies of primary biliary cirrhosis recognize 78-92-kD and 96-100-kD proteins of nuclear bodies. Clin Exp Immunol (1991) 1.04
The detached osteochondral fragment as a source of cells for autologous chondrocyte implantation (ACI) in the ankle joint. Osteoarthritis Cartilage (2005) 1.03
Localization of neutrophil cationic proteins and loss of anionic charges in glomeruli of patients with systemic lupus erythematosus glomerulonephritis. Clin Immunol Immunopathol (1982) 1.03
Serological screening for coeliac disease in vitiligo and alopecia areata. Br J Dermatol (1997) 1.03
Oxidative damage and erythrocyte membrane transport abnormalities in thalassemias. Blood (1994) 1.03
Mortality risk for patients receiving hemodiafiltration versus hemodialysis. Kidney Int (2006) 1.03
Clinical findings and anti-neuronal antibodies in coeliac disease with neurological disorders. Scand J Gastroenterol (2002) 1.02
Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease. Gut (1995) 1.02
Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA. Liver (1994) 1.02
Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis (2006) 1.01
Release of platelet-activating factor from ischemic-reperfused rabbit heart. Am J Physiol (1989) 1.01
Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood (1996) 1.01
Hepatitis C viraemia in adults with type 2 autoimmune hepatitis. J Med Virol (1991) 1.01
Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment Pharmacol Ther (2005) 1.00
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol (2006) 1.00
IgA anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening. Save both money and monkeys. Dig Dis Sci (1995) 0.99
The role of platelet-activating factor in inflammation. Clin Immunol Immunopathol (1990) 0.99
Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes. Proc Natl Acad Sci U S A (1986) 0.99
Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: role of basophil-derived PAF in immune complex deposition. J Immunol (1982) 0.99
Tumor-derived microvesicles and the cancer microenvironment. Curr Mol Med (2013) 0.98
Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C. J Hepatol (1994) 0.96
Anti-HCV testing in autoimmune hepatitis and primary biliary cirrhosis. Lancet (1990) 0.96
HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease. Clin Exp Immunol (1987) 0.96
Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. QJM (2004) 0.96
Tumor necrosis factor induces contraction of mesangial cells and alters their cytoskeletons. Kidney Int (1990) 0.96
Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology (1997) 0.96
Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther (2007) 0.95
Correlation between Ito cells and fibrogenesis in an experimental model of hepatic fibrosis. A sequential stereological study. Liver (1983) 0.95
IgA subclass antibodies to gliadin in serum and intestinal juice of patients with coeliac disease. Clin Exp Immunol (1990) 0.95
Ca(2+)-activated K+ channels of human and rabbit erythrocytes display distinctive patterns of inhibition by venom peptide toxins. J Membr Biol (1995) 0.95
HBsAg-induced hypertrophic smooth endoplasmic reticulum as a target for liver-kidney microsomal (LKM) antibodies. Clin Exp Immunol (1981) 0.94
'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol (2004) 0.94